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ABSTRACT 
 
OBJECTIVE: The objective of this selective EBM review is to determine if ginger is effective 
at ameliorating chemotherapy induced nausea when used adjunct to standard antiemetics in 
cancer patients.  
 
STUDY DESIGN: Systematic review of three randomized controlled trials published in 2015, 
2017, and 2018.  
 
DATA SOURCES: Data sources for this review were articles published in peer-reviewed 
journals using PubMed and Cochrane Databases.  
 
OUTCOME(S) MEASURED: The outcomes measured are ginger’s effect on the incidence of 
chemotherapy induced nausea, ginger’s effect on the severity of chemotherapy induced nausea, 
and ginger’s effect on delayed nausea in patients taking chemotherapy. 
 
RESULTS: Two out of three RCTs found no statistically significant difference in nausea ratings 
when comparing the addition of ginger to the control group. Arslan, M et al. (Clinical J Oncol 
Nurs. 2015;19(5): E92-E97. doi:10.1188/15.CJON.E92-E97) found that ginger was significantly 
effective at reducing the severity of chemotherapy induced nausea in breast cancer patients with 
a with a p-value of <0.0001. Li X, et al. (Integr Cancer Ther. 2018;17(3):747-754. doi: 
10.1177/1534735417753541), however, found that ginger was not significantly effective at 
reducing the incidence of chemotherapy induced nausea, with a p-value of 0.214 and NNT of 14. 
Bossi P, et al. (Ann Oncol. 2017; 28(10):2547–2551. doi: 10.1093/annonc/mdx315) also found 
that ginger was not effective at reducing delayed nausea in patients taking chemotherapy, with a 
p-value of 0.379 and NNT of 15.  
 
CONCLUSIONS: The use of ginger to aid in amelioration of chemotherapy induced nausea 
amongst cancer patients has a hopeful outlook, however, the current studies conducted on the 
topic are inconclusive, and therefore further research should be done before establishing a 
definitive conclusion. 
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INTRODUCTION 
 Cancer is a set of conditions characterized by uncontrolled cell division leading to 
growths or disruptions in the normal cell renewal process, and is sometimes associated with the 
ability to proliferate and move to other tissues.1 Chemotherapy is a cancer treatment commonly 
used that works by damaging and destroying cancer cells.  However, it also damages healthy 
cells that line the oral and gastric mucosa.1 This damage partially explains why nausea is one of 
the most common and distressing side effects of chemotherapy treatment.1 Chemotherapy 
induced nausea is often treated with pharmacological antiemetic therapy, however, most patients 
report experiencing relief from vomiting with standard therapy, but little relief from the symptom 
of nausea with this treatment, resulting in a decreased quality of life as well as reduced 
adherence to chemotherapy regimen. 2    
 Physician assistants in a variety of settings may work with patients suffering from 
chemotherapy induced nausea, as cancer patients usually seek care from a team of providers 
rather than a single oncologist in today’s healthcare model. Cancer is also becoming less rare, as 
it is now one of the leading causes of death and chronic disease, and the number of cancer cases 
is on the rise.1 In 2016, there were around 15 million people living with cancer, and this number 
is expected to increase by 20 percent by 2020. 1 80 percent of cancer patients experience 
chemotherapy induced nausea, and patients rate nausea as the most troublesome side effect of 
chemotherapy.1 The overall cost of chemotherapy induced nausea exceeds 500 million dollars 
yearly and accounts for over 8 million healthcare visits. 3 
 Chemotherapy induced nausea is believed to be due to innervation between the medulla 
oblongata and the gut via the vagal nerve and involvement of neurotransmitters such as 
serotonin, dopamine, and neurokinin. 2 Known risk factors for developing chemotherapy induced 
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nausea include being under the age of 50, being female sex, having symptoms from previous 
doses of chemotherapy agents, and higher doses of chemotherapy use. 2 Patients tolerate different 
types and doses of chemotherapy agents differently depending on each person for reasons that 
remain unknown.  Chemotherapy induced nausea can be labeled as either anticipation-related, 
acute, or delayed. 2 Anticipation related nausea occurs prior to administration of chemotherapy, 
acute nausea occurs in less than one day, and delayed nausea occurs 24 hours or more after 
therapy is initiated. 2 
 Usual treatment of chemotherapy induced nausea consists of a combination of 
antiemetics such as ondansetron and palonosetron (serotonin antagonists), dexamethasone (a 
steroid), and aprepitant (a neurokinin inhibitor.) 3 Other therapies commonly used include 
metoclopramide and cannabinoid agonists. 3 Much like chemotherapy and any other 
pharmacological agents, antiemetic use can be associated with side effects that are undesirable 
and they may not be fully effective by themselves at relieving nausea symptoms. 3 Ginger is 
known for its popularity as both a spice used in Asian dishes and as a chinese medicinal herb for 
nausea and general gastrointestinal upset. 2 Since ginger has proven to ease general stomach 
upset, and is effective at treating sea sickness and pregnancy induced nausea, it may also provide 
relief to those suffering from nausea due to chemotherapy agent use. 5 
OBJECTIVE 
The objective of this evidence-based medicine (EBM) review is to determine if ginger is 
effective at ameliorating chemotherapy induced nausea when used adjunct to standard 
antiemetics in cancer patients.  
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METHODS 
The three studies used in this review include an unblinded RCT, and two double blinded RCTs. 
Each article compares a control group that used a placebo with standard antiemetic only to an 
intervention group which used ginger in either powder or capsule form along with standard 
antiemetics. The studies used aimed to investigate outcomes of whether ginger could ameliorate 
chemotherapy induced nausea incidence using a visual analog scale, ginger’s effect on nausea 
severity using a patient information form, and the outcome of delayed nausea incidence using a 
multinational cancer antiemesis tool. Populations in each study included adult patients with solid 
tumors, female adults with stage two or three breast cancer, and adults with lung cancer, all of 
which were taking cisplatin or other chemotherapy agents. Inclusion criteria for this review 
included all races and sexes of adult patients with primary research literature published in the last 
5 years. Exclusion criteria included studies done on animal populations, and outcomes that were 
not relevant to improving the patient’s QOL (quality of life). 
 The articles used for this review were chosen based on their ability to effectively answer 
my clinical question and were published between 2015 and 2018. They were published in 
English and selected from PubMed and Cochrane databases. The key words used for research 
included “CINV”, “ginger”, and “cancer”. The statistics used were p values, number needed to 
treat (NNT), and t- scores. All research was done on my own, without the aid of others.  
OUTCOMES MEASURED 
Li et al. measured the incidence of delayed chemotherapy induced nausea with the 
multinational association for supportive cancer care anti-emesis tool, which is a form using 
options (0) no nausea, or (1) yes as option choices for the incidence of delayed nausea. 4 Arslan 
et al. measured nausea severity using a patient information form with a numeric scale as follows 
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0-10: 1-2 being mild, 3-6 being moderate, and 7-10 being severe as options for patients to select. 
5 Bossi et al. used the visual analog scale- a horizonal meter ranging from 0mm (none)-100 
mm(extreme) with >5mm indicating incidence in order to evaluate delayed nausea incidence. 6 
Table 1: Demographics and Characteristics of included studies 
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RESULTS 
This review assesses if ginger is effective at ameliorating chemotherapy induced nausea 
when used adjunct to standard antiemetics. Data from Bossi, P et al. and Li, X et al. is 
dichotomous, while data from Arslan, M et al. is continuous and cannot be converted. Patient 
populations and outcomes assessed varied slightly among studies, which may have effected the 
results of this review.  
The study conducted by Bossi P, et al. aimed to determine the efficacy of ginger in 
reducing delayed chemotherapy induced nausea in patients taking a high dose of cisplatin. 6 The 
study took place in an oncological center and included patients of both genders with mostly lung 
and head or neck tumors. 6 The study excluded patients with coagulation disorders and patients 
with a history of seizures or alcohol abuse, as these factors could skew the results. 6 
Patients in both intervention and control groups received 2 cycles of cisplatin along with 
standard antiemetic therapy, which included aprepitant, ondansetron, and dexamethasone. 6 The 
first cycle would range from days 2-21 and the second cycle would range from days 23-46. 6 The 
intervention group took a daily dose of 160 mg after eating a meal while taking chemotherapy. 6 
The control group took the same amount of placebo pills with the same instructions. 6 Patients 
were contacted by phone every few days to ensure proper adherence to directions. 6 The delayed 
incidence of nausea was evaluated using the visual analog scale on days 1 and 6 of the first and 
second cycle. 6 The patient would select on a sale of 0-100 mm the number which best 
corresponds to their feelings of nausea. 6 The study did have a 39% withdraw rate due to reasons 
including side effects, adverse events, protocol violations, health status, and intolerance. 6 
Dropout rate should not have effected results, as the dropout rate was even among groups. 6 
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Efficacy was measured by comparing nausea incidence VAS (visual analog scale) scores 
>5mm during the first and second cycles of chemotherapy. 6 The number of patients with nausea 
incidence in the ginger group were compared to the number in the control group to assess if the 
difference was significant. 6 No difference was seen in the control or experimental groups in 
terms of delayed nausea incidence (95% CI =1.36, p= 0.379), as VAS scores were similar 
between both groups. 6 Treatment compliance was difficult in this study, however, it was not 
significantly different between groups, and patients who were non-compliant were dropped from 
the study. 6 
Safety was assessed by reporting adverse events, which mainly consisted of GI side 
effects. 6 Most safety related adverse events in the ginger group were mild such as minor 
dyspepsia, whereas the control group contained more serious adverse events, most likely not 
related to treatment. 6 
Table 2 Visual analog scale of delayed nausea incidence during 1st and 2nd cycles of therapy 
 Ginger n (%) Placebo n(%) Odds ratio 
(95% CI) 
P value 
Cycle 1 77 (67.5) 71 (66.4) 1.06 (0.60/1.85) 0.851 
Cycle 2 52 (65.8) 55 (72.4) 1.36 (0.69/2.70) 0.379 
 
 The study done by Arslan, M et al. aims to determine ginger’s effect on the severity of 
chemotherapy induced nausea in patients with breast cancer taking anthracycline, 
cyclophosphamide, doxorubicin, and 5-fluorouracil, who are also receiving palonosetron as an 
antiemetic. 5 The patient population included 60 patients partaking in chemotherapy at an 
outpatient oncology clinic and included only female patients with stage 2 or 3 breast cancer who 
have received prior surgical treatment and are in the second cycle of treatment with 
chemotherapy or further and have complained of nausea of severity 3 or more with past usage of 
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chemotherapy agents. 5 The study excluded male patients, patients with cancer of other sites, 
patients in their first cycle of chemotherapy, and patients without a history of nausea when taking 
regimens. 5 Most patients were around age 50 and married with children. No significant 
differences were seen in terms of cancer staging or nausea severity in previous episodes between 
groups. 5 
 Patients were followed throughout 2 cycles of chemotherapy. Nausea was assessed four 
times each day for five days in a row by each patient starting on the first day of chemotherapy 
initiation. 5 Patients recorded their nausea severity using the patient information form, which 
provided a numeral scale. 1-2 rated as mild, 3-6 would rate as moderate and 7-10 would be 
severe. Patients would be contacted each day as a reminder to log their nausea ratings. 5 Patients 
in the intervention group were given a total daily dose of 1000 mg powered ginger mixed with a 
spoonful of yogurt half an hour before the start of chemotherapy for three days along with 
standard antiemetics. 5 Patients in the control group were given only the standard antiemetics 
provided by the oncology center which included palonosetron, dexamethasone, ranitidine, and an 
antihistamine via IV route. 5 This study had a 0% dropout rate, as all patients who entered the 
trial completed the trial and were counted in the study. 5 
 Efficacy was measured using mean scores of nausea severity for five days. 5 The mean 
scores were compared between the intervention and the control groups. A statistically significant 
difference was seen on days 2-5 with respects to the intervention group. 5 This indicated that 
nausea severity was lower in the intervention group during those days (p value <0.05). 5 There 
was a mean nausea score of 5 +/- 1.5 in the control group, and a score of 3 +/- 1.5 in the 
intervention group after the research intervention. 5 There were no issues with safety or 
tolerability in this study, as ginger was taken from capsules and no adverse effects were 
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recorded. 5 Compliance was the same in both groups and there were no issues noted with 
compliance during the study. 5 
Table 3 Changes in nausea severity Days 1-5 
Day mean t p 
1 control 
intervention 
1.2 +/- 1.1 























Table 4 Overall changes in Nausea Severity Before and After the Administration of Ginger 
 Mean Nausea Severity 
Before Ginger 





5.2 +/- 1.5   p=0.9 
5.3 +/- 1 
5.1 +/- 1.5   p<0.001** 




 The study conducted by Li, X et al. aimed to determine ginger’s effect on the incidence 
of chemotherapy induced nausea. 4 Most patients in this study were males. 4 The experimental 
group was given a total daily dose of 1000 mg of ginger for 5 days beginning on the first day of 
chemotherapy. 4 Patients took the pills 30 minutes before taking chemotherapy. Patients in the 
control group were given the same instructions, however, they received a placebo pill filled with 
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corn starch. All patients also received standard antiemetic therapy consisting of ondansetron, 
aprepitant, and dexamethasone. 4 The trial took place on a cancer floor of a hospital. The 
incidence of nausea was measured with the Multinational Association for Supportive Care in 
Cancer Antiemesis Tool. 4 They used scoring as 0 for no or 1 for yes to record if nausea was 
experienced. 4 Patients were reminded to record their findings in person and via telephone. 4 
 Efficacy was measured using percentages and p values. Control and intervention group 
values were compared to asses if differences were seen in nausea incidence with intervention. 4 
With a p value of 0.214 and NNT of 14, no significant difference was seen in nausea incidence 
between the control group and the intervention group, meaning that ginger did not have any 
added benefit to patients in this study. 4 
Six patients dropped out of the study due to lack of compliance, however, the dropout 
rate was not significantly different between the two groups. 4 Adverse events were accounted for 
via self- report. The adverse events seen in this study included drowsiness, dry mouth, heart 
burn, and flushing, however, there was no significant difference in adverse events between the 
two groups and they were not believed to be due to the study materials. 4  
Table 5 Incidence of nausea in control and intervention groups 
Placebo (n=69), n (%) Ginger (n=71), N (%) P value 




 Both Arslan et al. and Bossi P, et al. had mild safety concerns related to adverse effects of 
treatment or other reasons aside from treatment, however, they should not have greatly affected 
these studies. Xi, L et al. did not have any safety concerns. 4  
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Table 6 Safety issues among studies 
 Adverse events Due to ginger Y/N? Mild or severe 
Arslan et al. 5 Both groups: Dry 
mouth, heart burn, 
flushing, drowsiness 
No- most likely due to 
chemo 
Severe 
Bossi, P et al. 6 Ginger group: GI SE/ 
dyspepsia, belching, gas  










Xi, L et al. 4 none n/a n/a 
 
DISCUSSION 
 The studies conducted by Li, X et al. 4 and Bossi, P et al. 6 showed no differences in acute 
or delayed nausea incidence when ginger was added on to standard antiemetic regimen. 
However, a lower nausea severity was seen in the intervention group in the study conducted by 
Arslan, M et al. 5 The findings in these studies support the fact that although ginger has been 
used as a long-time natural aid in relief of gastrointestinal upset, more research is needed to 
confirm if it is an effective aid in reducing nausea that is chemotherapy induced. Although Bossi 
P et al. noted that ginger did not change the incidence of nausea seen in patients, the functional 
living index emesis (FLIE) questionnaires (which were not directly related to the outcome) 
indicated that a better quality of life was rated amongst patients in the ginger group, specifically 
among females and head and neck cancer patients, indicating some hopeful outlooks for the 
future of ginger use as an aid to decrease generally undesirable symptoms of chemotherapy 
agents such as nausea. 6 
 One advantage of using ginger is that it is cheap and widely available for use, so it is a 
practical treatment when chosen. Ginger’s other uses include morning sickness in pregnancy, 
postoperative nausea and vomiting, arthritic pain, migraine headaches, and motion sickness. 7 
Ginger is contraindicated in those with a previous allergic reaction or gallbladder disease and is 
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used with caution in bleeding disorders, heart disease, diabetes mellitus and hypertension. 7 
There are currently no black box warnings for ginger therapy, however, it is sold as an herbal 
supplement and is not currently FDA approved in the U.S., so it would not be covered by 
insurance. 7 
 Limitations of this review include differences in populations i.e. two studies used mostly 
male patients and one study used all female patients. Another limitation is that each article 
focused on different types of cancer, which may have affected treatment outcomes to some 
extent. Some studies had a large drop out rate due to side effects or patients not complying with 
the regimen. Limitations of the studies themselves included difficulty blinding patients, use of 
different doses and formulations of ginger, slight differences in medications used for standard 
antiemetic therapy, and possibilities of ginger interacting with routine antiemetics in a way that 
may hinder one of the two from working as effectively. 
CONCLUSION 
 All in all, the future of ginger use as an aid along with standard antiemetics to ameliorate 
chemotherapy induced nausea may be promising, however, there is currently not enough 
evidence to support this claim. Future researchers would benefit from keeping ginger doses even 
amongst studies and focusing on correlation with ginger use benefiting nausea outcomes in 
specific cancer subsets that have shown to be responsive to ginger in past studies. It would also 
help to follow patients over a longer time frame and keep patient populations consistent.
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